These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 16139161)

  • 21. Traumatic hemoptysis treated with recombinant human factor VIIa.
    O'Connor JV; Stein DM; Dutton RP; Scalea TM
    Ann Thorac Surg; 2006 Apr; 81(4):1485-7. PubMed ID: 16564298
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effectiveness of recombinant activated factor VII in haemorragic cancer-related disseminated intravascular coagulation: a case report.
    Pierfranceschi MG; Imberti D; Orlando S; Vallisa D; Michieletti E
    Blood Transfus; 2011 Jul; 9(3):336-8. PubMed ID: 21251460
    [No Abstract]   [Full Text] [Related]  

  • 23. [Medical-surgical management of traumatic cardiac rupture: Relevance of recombinant activated factor VII].
    Blasco V; Leone M; Visintini P; Antonini F; Albanèse J; Martin C
    Ann Fr Anesth Reanim; 2008 Sep; 27(9):719-22. PubMed ID: 18755569
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use of recombinant activated factor VII in a patient with severe thrombocytopenia due to myelodysplastic syndrome with uncontrolled gastrointestinal bleeding.
    Ozcelik T; Ozkocaman V; Ozkalemkas F; Ali R; Altundal Y; Ozkan A; Tunali A
    Blood Coagul Fibrinolysis; 2007 Jun; 18(4):385-6. PubMed ID: 17473584
    [No Abstract]   [Full Text] [Related]  

  • 25. Recombinant activated factor VII for intractable bleeding post splenectomy in a patient with myeloproliferative disorder.
    El Kinge AR; Mahfouz RA; Shamseddine AI; Taher AT
    Blood Coagul Fibrinolysis; 2007 Sep; 18(6):577-9. PubMed ID: 17762536
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of recombinant activated factor VII in a case of severe postpartum haemorrhage.
    Verre M; Bossio F; Mammone A; Piccirillo M; Tancioni F; Varano M
    Minerva Ginecol; 2006 Feb; 58(1):81-4. PubMed ID: 16498374
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recombinant activated factor VII as an adjunctive therapy for bleeding control in severe trauma patients with coagulopathy: subgroup analysis from two randomized trials.
    Rizoli SB; Boffard KD; Riou B; Warren B; Iau P; Kluger Y; Rossaint R; Tillinger M;
    Crit Care; 2006; 10(6):R178. PubMed ID: 17184516
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Correction of coagulopathy in warfarin associated cerebral hemorrhage.
    Aiyagari V; Testai FD
    Curr Opin Crit Care; 2009 Apr; 15(2):87-92. PubMed ID: 19300085
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The sex kitten of bioethics? Research ethics comes of age.
    Dresser R
    Hastings Cent Rep; 2008; 38(5):5. PubMed ID: 18947127
    [No Abstract]   [Full Text] [Related]  

  • 30. Failure to report and provide commentary on research ethics board approval and informed consent in medical journals.
    Finlay KA; Fernandez CV
    J Med Ethics; 2008 Oct; 34(10):761-4. PubMed ID: 18827111
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Thromboelastography to direct the administration of recombinant activated factor VII in a child with traumatic injury requiring massive transfusion.
    Nylund CM; Borgman MA; Holcomb JB; Jenkins D; Spinella PC
    Pediatr Crit Care Med; 2009 Mar; 10(2):e22-6. PubMed ID: 19265363
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Experiences with recombinant activated factor VII in the treatment of severe refractory thrombocytopenia.
    Wróbel G; Dobaczewski G; Patkowski D; Sokół A; Grotthus E
    Pediatr Blood Cancer; 2006 Oct; 47(5 Suppl):729-30. PubMed ID: 16933258
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recombinant activated factor VIIa in uncontrolled bleeding: a haemostasis laboratory study in non-haemophilia patients.
    Brandsborg S; Sørensen B; Poulsen LH; Ingerslev J
    Blood Coagul Fibrinolysis; 2006 Jun; 17(4):241-9. PubMed ID: 16651865
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Bleeding after cardiac surgery: the role of recombinant factor VIIa].
    von Heymann C; Spies C; Grubitzsch H; Schönfeld H; Sander M; Volk T
    Hamostaseologie; 2006 Aug; 26(3 Suppl 1):S77-87. PubMed ID: 16953296
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The use of recombinant activated factor VII in the circumcision operation in the case of a congenital factor VII deficiency.
    Canatan D; Eren E; Ozgüner IF; Duman H; Eren C; Büyükyavuz I; Savaş C
    Blood Coagul Fibrinolysis; 2007 Jun; 18(4):375-6. PubMed ID: 17473581
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Benefits of recombinant activated factor VII in complicated liver transplantation.
    Gala B; Quintela J; Aguirrezabalaga J; Fernández C; Fraguela J; Suárez F; Gómez M
    Transplant Proc; 2005 Nov; 37(9):3919-21. PubMed ID: 16386584
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Management of massive pulmonary embolism using recombinant activated Factor VII.
    Reyes G; Carrasco N; Muñoz T; Duarte J
    Eur J Cardiothorac Surg; 2008 Jun; 33(6):1144-5. PubMed ID: 18406163
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recombinant activated factor VII in cardiac surgery: experience from the Australian and New Zealand Haemostasis Registry.
    Dunkley S; Phillips L; McCall P; Brereton J; Lindeman R; Jankelowitz G; Cameron P
    Ann Thorac Surg; 2008 Mar; 85(3):836-44. PubMed ID: 18291152
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Activated recombinant factor VII for bleeding after a kidney transplant: reflections].
    Pajares A; Larrea L
    Rev Esp Anestesiol Reanim; 2006 Apr; 53(4):266-7; author reply 268. PubMed ID: 16711505
    [No Abstract]   [Full Text] [Related]  

  • 40. [Coagulation disorders in patients with trauma to the skull and brain: a frequent and potentially fatal combination].
    Haagh WA; van Pampus EC; van Zutphen SW; Brink PR
    Ned Tijdschr Geneeskd; 2006 Nov; 150(46):2530-5. PubMed ID: 17152328
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.